2 completed, 1 enrolling by invitation. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Enrolling by invitation 1 |
Follow Analytical Treatment Interruption: new trials by email Literature Review of Analytical Treatment Interruption trials Research Report on Analytical Treatment Interruption
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART Analytical Treatment Interruption - HIV | Phase 1 | Enrolling by invitation | National Institute of Allergy and Infectious Diseases (NIAID) | 50 | 2025-09-08 | 2026-10-01 |
| 3BNC117 and 10-1074 in ART-treated Individuals 3BNC117, 10-1074, Analytical treatment interruption - Human Immunodeficiency Virus | Phase 1 | Completed | Rockefeller University | 26 | 2018-06-05 | 2025-10-01 |
| 3BNC117 and 10-1074 in HIV-infected Individuals 3BNC117, 10-1074, Analytical treatment interruption - Human Immunodeficiency Virus (HIV) | Phase 1 | Completed | Rockefeller University | 34 | 2016-06-01 | 2018-08-21 |
Acquired Immunodeficiency Syndrome (2) · HIV Infections (1)
Rockefeller University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (3) · Germany (1)
Marina Caskey, MD (2) · Michael C Sneller, M.D. (1)